Azathioprine

Basic Information

CAS ID: 446-86-6
Molecular Formula: C9H7N7O2S
Molecular Weight: 277.3 g/mol
Monoisotopic Mass: 277.0382 g/mol
Class: Small Molecule
Natural Product: No
Other Names: OPRISINE 50 | IMURAN | AZASAN | BW-57-322 | IMMUNOPRIN 50 | AZATHIOPRINE SODIUM | AZAPRESS | KENTAPRINE | AZAMUNE | AZATHIOPRINE | BERKAPRINE
Analysis: Drug repositioning mechanism analysis

N N S N N N NH N+ O O-

Compound Structure and Identifier

InChI: InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13) See All
InChI Key: LMEKQMALGUDUQG-UHFFFAOYSA-N
Smiles: Cn1cnc(c1Sc2ncnc3nc[nH]c23)[N+](=O)[O-] See All
Molfile: Download

Related Target

Related Fibrosis Property

Trial Record 1

ClinicalTrial ID NCT00518310 Disease Idiopathic pulmonary fibrosis
Phase Not Applicable Status Unknown
First Received August 20, 2007 Last Verified August 20, 2007
Sponsor Thorax National Institute

Trial Record 2

ClinicalTrial ID NCT00262405 Disease Idiopathic pulmonary fibrosis
Phase Phase 2 Status Completed
First Received December 6, 2005 Last Verified December 3, 2015
Sponsor University of Michigan

Trial Record 3

ClinicalTrial ID NCT00052039 Disease Pulmonary fibrosis,
Phase Phase 3 Status Terminated
First Received January 22, 2003 Last Verified November 6, 2007
Sponsor InterMune

Trial Record 4

ClinicalTrial ID NCT00650091 Disease Pulmonary fibrosis
Phase Phase 3 Status Completed
First Received April 1, 2008 Last Verified June 2, 2015
Sponsor Duke University

Related Link

PubChem: 2265
ChEMBL: CHEMBL1542